Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 1;327(3):L327-L340.
doi: 10.1152/ajplung.00052.2024. Epub 2024 May 21.

Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023

Affiliations
Review

Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023

Robert E Hynds et al. Am J Physiol Lung Cell Mol Physiol. .

Abstract

Repair and regeneration of a diseased lung using stem cells or bioengineered tissues is an exciting therapeutic approach for a variety of lung diseases and critical illnesses. Over the past decade, increasing evidence from preclinical models suggests that mesenchymal stromal cells, which are not normally resident in the lung, can be used to modulate immune responses after injury, but there have been challenges in translating these promising findings to the clinic. In parallel, there has been a surge in bioengineering studies investigating the use of artificial and acellular lung matrices as scaffolds for three-dimensional lung or airway regeneration, with some recent attempts of transplantation in large animal models. The combination of these studies with those involving stem cells, induced pluripotent stem cell derivatives, and/or cell therapies is a promising and rapidly developing research area. These studies have been further paralleled by significant increases in our understanding of the molecular and cellular events by which endogenous lung stem and/or progenitor cells arise during lung development and participate in normal and pathological remodeling after lung injury. For the 2023 Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases Conference, scientific symposia were chosen to reflect the most cutting-edge advances in these fields. Sessions focused on the integration of "omics" technologies with function, the influence of immune cells on regeneration, and the role of the extracellular matrix in regeneration. The necessity for basic science studies to enhance fundamental understanding of lung regeneration and to design innovative translational studies was reinforced throughout the conference.

Keywords: airway epithelium; alveolar epithelium; extracellular matrix; immune cells; lung regeneration.

PubMed Disclaimer

Conflict of interest statement

A.L.R. and D.J.W. received funding from National Heart, Lung, and Blood Institute R13 Conference Grant and the National Science Foundation to support the conference. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Countries and states represented at the 2023 conference. Pie charts depict geographic location of attendees by country (A) and US state (B).
Figure 2.
Figure 2.
Representation of sex, race, and ethnicity at the 2023 conference. A: bar chart shows change in inclusion of underrepresented groups (minorities and women) since the inception of the conference. Pie charts show attendance by sex (B), ethnicity (C), and race (D).

References

    1. Ikonomou L, Magnusson M, Dries R, Herzog EL, Hynds RE, Borok Z, Park JA, Skolasinski S, Burgess JK, Turner L, Mojarad SM, Mahoney JE, Lynch T, Lehmann M, Thannickal VJ, Hook JL, Vaughan AE, Hoffman ET, Weiss DJ, Ryan AL. Stem cells, cell therapies, and bioengineering in lung biology and disease 2021. Am J Physiol Lung Cell Mol Physiol 323: L341–L354, 2022. doi:10.1152/ajplung.00113.2022. - DOI - PMC - PubMed
    1. Ryan AL, Ikonomou L, Atarod S, Bolukbas DA, Collins J, Freishtat R, Hawkins F, Gilpin SE, Uhl FE, Uriarte JJ, Weiss DJ, Wagner DE. Stem cells, cell therapies, and bioengineering in lung biology and diseases 2017. An Official American Thoracic Society Workshop Report. Am J Respir Cell Mol Biol 61: 429–439, 2019. doi:10.1165/rcmb.2019-0286ST. - DOI - PMC - PubMed
    1. Wagner DE, Ikonomou L, Gilpin SE, Magin CM, Cruz F, Greaney A, Magnusson M, Chen Y-W, Davis B, Vanuytsel K, Rolandsson Enes S, Krasnodembskaya A, Lehmann M, Westergren-Thorsson G, Stegmayr J, Alsafadi HN, Hoffman ET, Weiss DJ, Ryan AL. Stem cells, cell therapies, and bioengineering in lung biology and disease 2019. ERJ Open Res 6: 00123-2020, 2020. doi:10.1183/23120541.00123-2020. - DOI - PMC - PubMed
    1. Weiss DJ. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc 10: S45–S97, 2013. doi:10.1513/AnnalsATS.201304-090AW. - DOI - PMC - PubMed
    1. Weiss DJ, Bertoncello I, Borok Z, Kim C, Panoskaltsis-Mortari A, Reynolds S, Rojas M, Stripp B, Warburton D, Prockop DJ. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 8: 223–272, 2011. doi:10.1513/pats.201012-071DW. - DOI - PMC - PubMed